# US 2023/0390236 A1 · Pharmaceutical composition for preventing or treating wound or scar, comprising benzbromarone

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0390236 A1
- Document ID: US20230390236A1
- Status: Published application
- Kind: A1
- Application number: 18/254,211
- Filed: 2021-11-29
- Published: 2023-12-07
- Earliest claimed: 2020-11-30
- Assignees: Innovo Therapeutics Inc.
- Applicants: Innovo Therapeutics Inc.
- Inventors: Dong Chul LIM; Jung Gyu PARK
- Web page: https://patentgrep.com/patent/US20230390236A1

## CPC

- A61K 31/343: condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided is a method for preventing or treating a wound or scar comprising administering to a subject in need thereof a pharmaceutical composition comprising benzbromarone as an active ingredient, wherein benzbromarone inhibits the function of heat shock protein 47 (HSP47), or inhibits the accumulation of collagen by reducing collagen overproduction cells.

## Claims

### Claim at position 1

-8. (canceled)

### Claim 9

A method for preventing or treating keloid scars or hypertrophic scars, comprising: administering to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of benzbromarone, and thereby preventing or treating the scars.

### Claim 10 (depends on 9)

The method of claim 9, wherein the composition further comprises a pharmaceutically acceptable diluent or carrier.

### Claim 11 (depends on 9)

The method of claim 9, wherein the treating is via inhibiting HSP47 (Heat shock protein 47).

### Claim 12 (depends on 9)

The method of claim 9, wherein the treating is via inhibiting collagen biosynthesis.

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15 (depends on 9)

The method of claim 9, wherein the composition reduces the area of the wound or scar.

### Claim 16

A method for reducing the size of a skin scar comprising: administering to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of benzbromarone, and thereby reducing the size of the skin scar.

### Claim 17 (depends on 16)

The method of claim 16, further comprising a pharmaceutically acceptable diluent or carrier.
